SAT0548 Plasma CGRP Concentrations Were Not Associated With Patient OA Symptoms or Response to Galcanezumab, a Monoclonal Antibody Against CGRP
doi 10.1136/annrheumdis-2017-eular.2155
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism